XML 37 R22.htm IDEA: XBRL DOCUMENT
v3.20.2

Significant Accounting Policies (Tables) | 9 Months Ended
--- | ---
Sep. 30, 2020
Accounting Policies [Abstract] |
Schedule of Cash, Cash Equivalents, and Restricted Cash | The following is a reconciliation of cash and cash equivalents on the unaudited condensed consolidated balance sheets to total cash, cash equivalents and restricted cash on the unaudited condensed consolidated statements of cash flows:
In millions | September 30, 2020 |  | December 31, 2019
Cash and cash equivalents | $ | 9,256 |  |  | $ | 5,683 |
Restricted cash (included in other assets) | 276 |  |  | 271 |
Total cash, cash equivalents and restricted cash in the statements of cash flows | $ | 9,532 |  |  | $ | 5,954 |
Accounts Receivable, Net | Accounts receivable, net is composed of the following:
In millions | September 30, 2020 |  | December 31, 2019
Trade receivables | $ | 7,265 |  |  | $ | 6,717 |
Vendor and manufacturer receivables | 10,528 |  |  | 7,856 |
Premium receivables | 2,852 |  |  | 2,663 |
Other receivables | 3,171 |  |  | 2,381 |
Total accounts receivable, net | $ | 23,816 |  |  | $ | 19,617 |
Disaggregation of Revenue | The following tables disaggregate the Company’s revenue by major source in each segment for the three and nine months ended September 30, 2020 and 2019:
In millions | Pharmacy Services |  | Retail/ LTC |  | Health Care Benefits |  | Corporate/ Other |  | Intersegment Eliminations |  | Consolidated Totals
Three Months Ended September 30, 2020 |  |  |  |  |  |  |  |  |  |
Major goods/services lines: |  |  |  |  |  |  |  |  |  |  |
Pharmacy | $ | 35,505 |  |  | $ | 17,608 |  |  | $ | — |  |  | $ | — |  |  | $ | (10,051) |  |  | $ | 43,062 |
Front Store | — |  |  | 4,740 |  |  | — |  |  | — |  |  | — |  |  | 4,740 |
Premiums | — |  |  | — |  |  | 17,165 |  |  | 17 |  |  | — |  |  | 17,182 |
Net investment income | — |  |  | — |  |  | 121 |  |  | 83 |  |  | — |  |  | 204 |
Other | 206 |  |  | 377 |  |  | 1,412 |  |  | 16 |  |  | (143) |  |  | 1,868 |
Total | $ | 35,711 |  |  | $ | 22,725 |  |  | $ | 18,698 |  |  | $ | 116 |  |  | $ | (10,194) |  |  | $ | 67,056 |
Pharmacy Services distribution channel: |  |  |  |  |  |  |  |  |  |
Pharmacy network (1) | $ | 21,473 |  |  |  |  |  |  |  |  |  |  |
Mail choice (2) | 14,032 |  |  |  |  |  |  |  |  |  |  |
Other | 206 |  |  |  |  |  |  |  |  |  |  |
Total | $ | 35,711 |  |  |  |  |  |  |  |  |  |  |
Three Months Ended September 30, 2019 |  |  |  |  |  |  |  |  |  |
Major goods/services lines: |  |  |  |  |  |  |  |  |  |  |
Pharmacy (3) | $ | 35,872 |  |  | $ | 16,687 |  |  | $ | — |  |  | $ | — |  |  | $ | (9,999) |  |  | $ | 42,560 |
Front Store | — |  |  | 4,614 |  |  | — |  |  | — |  |  | — |  |  | 4,614 |
Premiums | — |  |  | — |  |  | 15,507 |  |  | 32 |  |  | — |  |  | 15,539 |
Net investment income | — |  |  | — |  |  | 146 |  |  | 117 |  |  | — |  |  | 263 |
Other (3) | 146 |  |  | 165 |  |  | 1,528 |  |  | 3 |  |  | (8) |  |  | 1,834 |
Total | $ | 36,018 |  |  | $ | 21,466 |  |  | $ | 17,181 |  |  | $ | 152 |  |  | $ | (10,007) |  |  | $ | 64,810 |
Pharmacy Services distribution channel: |  |  |  |  |  |  |  |  |  |
Pharmacy network (1) (3) | $ | 22,411 |  |  |  |  |  |  |  |  |  |  |
Mail choice (2) (3) | 13,461 |  |  |  |  |  |  |  |  |  |  |
Other | 146 |  |  |  |  |  |  |  |  |  |  |
Total | $ | 36,018 |  |  |  |  |  |  |  |  |  |  |
In millions | Pharmacy Services |  | Retail/ LTC |  | Health Care Benefits |  | Corporate/ Other |  | Intersegment Eliminations |  | Consolidated Totals
Nine Months Ended September 30, 2020 |  |  |  |  |  |  |  |  |  |
Major goods/services lines: |  |  |  |  |  |  |  |  |  |  |
Pharmacy | $ | 104,924 |  |  | $ | 51,833 |  |  | $ | — |  |  | $ | — |  |  | $ | (30,032) |  |  | $ | 126,725 |
Front Store | — |  |  | 14,601 |  |  | — |  |  | — |  |  | — |  |  | 14,601 |
Premiums | — |  |  | — |  |  | 51,699 |  |  | 50 |  |  | — |  |  | 51,749 |
Net investment income | — |  |  | — |  |  | 341 |  |  | 209 |  |  | — |  |  | 550 |
Other | 659 |  |  | 702 |  |  | 4,324 |  |  | 33 |  |  | (191) |  |  | 5,527 |
Total | $ | 105,583 |  |  | $ | 67,136 |  |  | $ | 56,364 |  |  | $ | 292 |  |  | $ | (30,223) |  |  | $ | 199,152 |
Pharmacy Services distribution channel: |  |  |  |  |  |  |  |  |  |
Pharmacy network (1) | $ | 63,109 |  |  |  |  |  |  |  |  |  |  |
Mail choice (2) | 41,815 |  |  |  |  |  |  |  |  |  |  |
Other | 659 |  |  |  |  |  |  |  |  |  |  |
Total | $ | 105,583 |  |  |  |  |  |  |  |  |  |  |
Nine Months Ended September 30, 2019 |  |  |  |  |  |  |  |  |  |
Major goods/services lines: |  |  |  |  |  |  |  |  |  |  |
Pharmacy (3) | $ | 103,983 |  |  | $ | 49,197 |  |  | $ | — |  |  | $ | — |  |  | $ | (31,416) |  |  | $ | 121,764 |
Front Store | — |  |  | 14,288 |  |  | — |  |  | — |  |  | — |  |  | 14,288 |
Premiums | — |  |  | — |  |  | 47,543 |  |  | 69 |  |  | — |  |  | 47,612 |
Net investment income | — |  |  | — |  |  | 458 |  |  | 347 |  |  | — |  |  | 805 |
Other (3) | 435 |  |  | 543 |  |  | 4,453 |  |  | 7 |  |  | (20) |  |  | 5,418 |
Total | $ | 104,418 |  |  | $ | 64,028 |  |  | $ | 52,454 |  |  | $ | 423 |  |  | $ | (31,436) |  |  | $ | 189,887 |
Pharmacy Services distribution channel: |  |  |  |  |  |  |  |  |  |
Pharmacy network (1) (3) | $ | 65,917 |  |  |  |  |  |  |  |  |  |  |
Mail choice (2) (3) | 38,066 |  |  |  |  |  |  |  |  |  |  |
Other | 435 |  |  |  |  |  |  |  |  |  |  |
Total | $ | 104,418 |  |  |  |  |  |  |  |  |  |  |
_____________________________________________ (1)Pharmacy Services pharmacy network is defined as claims filled at retail and specialty retail pharmacies, including the Company’s retail pharmacies and LTC pharmacies, but excluding Maintenance Choice® activity, which is included within the mail choice category. Maintenance Choice permits eligible client plan members to fill their maintenance prescriptions through mail order delivery or at a CVS Pharmacy retail store for the same price as mail order. (2)Pharmacy Services mail choice is defined as claims filled at a Pharmacy Services mail order facility, which includes specialty mail claims inclusive of Specialty Connect® claims picked up at a retail pharmacy, as well as prescriptions filled at the Company’s retail pharmacies under the Maintenance Choice program. (3)Certain prior year amounts have been reclassified for consistency with the current period presentation.
Contracts With Customers, Assets and Liabilities | The following table provides information about receivables and contract liabilities from contracts with customers:
In millions | September 30, 2020 |  | December 31, 2019
Trade receivables (included in accounts receivable, net) | $ | 7,265 |  |  | $ | 6,717 |
Contract liabilities (included in accrued expenses) | 75 |  |  | 73 |
During the nine months ended September 30, 2020 and 2019, the contract liabilities balance includes increases related to customers’ earnings in ExtraBucks Rewards or issuances of Company gift cards and decreases for revenues recognized during the period as a result of the redemption of ExtraBucks Rewards or Company gift cards and breakage of Company gift cards. Below is a summary of such changes:
| Nine Months Ended September 30,
In millions | 2020 |  | 2019
Contract liabilities, beginning of the period | $ | 73 |  |  | $ | 67 |
Rewards earnings and gift card issuances | 266 |  |  | 269 |
Redemption and breakage | (264) |  |  | (264) |
Contract liabilities, end of the period | $ | 75 |  |  | $ | 72 |

X
- References No definition available. + Details
Name: | us-gaap_AccountingPoliciesAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of receivable, contract asset, and contract liability from contract with customer. Includes, but is not limited to, change in contract asset and contract liability. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 606 -SubTopic 10 -Section 50 -Paragraph 10 -URI http://asc.fasb.org/extlink&oid=121604090&loc=SL49130551-203045 + Details
Name: | us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 606 -SubTopic 10 -Section 50 -Paragraph 5 -URI http://asc.fasb.org/extlink&oid=121604090&loc=SL49130545-203045 + Details
Name: | us-gaap_DisaggregationOfRevenueTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the various types of trade accounts and notes receivable and for each the gross carrying value, allowance, and net carrying value as of the balance sheet date. Presentation is categorized by current, noncurrent and unclassified receivables. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.3,4) -URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682 + Details
Name: | us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of supplemental cash flow information for the periods presented. + References No definition available. + Details
Name: | us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration